Setidegrasib, an emerging targeted therapy, has shown promising efficacy in a phase I trial involving patients with previously treated advanced pancreatic ductal adenocarcinoma (PDAC) and non-small cell lung cancer (NSCLC)…
In this edition of STAT's AI Prognosis: How to be a 'productive' biotech AI company, with Insilico Medicine CEO Alex Zhavoronkov, and more.
A delayed FDA decision for Orca Bio, new questions about pharma-telehealth tie-ups, and more
The FDA is moving toward allowing compounding pharmacies to produce injectable peptides that were banned over significant safety concerns
Around 300 resident doctors are leaving their postgraduate seats in government medical colleges in Maharashtra every year, reportedly due to excessive workload and long duty hours, a recent report by…
Here are the top health stories for the day:NMC Approves 49 Additional DM and MCh Seats for 2025-26 After AppealsThrough a recent notice, the National Medical Commission (NMC) approved additional…
New Delhi: Granules India Limited has announced that its wholly owned subsidiary, Granules Life Sciences Private Limited (GLS), has received a Voluntary Action Indicated (VAI) classification from the US Food…
New Delhi: Zydus Wellness Limited has informed that its wholly owned subsidiary, Zydus Wellness Products Limited (ZWPL), has received a GST order imposing a penalty of Rs 6.30 million along…
Mumbai: Global pharma major, Lupin Limited (Lupin) has announced that it has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application…
Hyderabad: The Telangana High Court recently dismissed a plea of postgraduate medical students challenging the evaluation process of their October 2025 examinations, observing that the matter is not within the…